ENTITY

Personalis Inc (PSNL US)

5
Analysis
Health Care • United States
Personalis, Inc. provides genomic sequencing and analytics solutions. The Company supports the development of personalized cancer vaccines and other next-generation cancer immunotherapies. Personalis serves customers worldwide.
more
bullish•Personalis Inc
•01 Oct 2025 06:38

S&P 500 and Russell 2000 4+ Month Uptrends Intact; Stick With Growth Themes and Metals/Mining

S&P 500 and Russell 2000 4+ Month Uptrends Intact; Stick With Growth Themes and Metals/Mining $GDX $XME $ARKG $ARKK $ARKQ $ARKX $ARKW $ARKF $GRAL...

Logo
423 Views
Share
bullish•Rigetti Computing
•26 Nov 2025 06:06

Back to Near-Term Bullish on SPX and Nasdaq 100; Supports Held at SPX 6480-6520 and QQQ $580-583

Back to Near-Term Bullish on $SPX and Nasdaq 100 $NDX; Crucial Supports Held at 6480-6520 on SPX and $580-$583 on $QQQ, we are near-term bullish as...

Logo
216 Views
Share
bearish•S&P 500 INDEX
•20 May 2020 07:34

U.S. Equity Strategy: Round Trip Back To Resistance

Our base case continues to be for near-term consolidation while the market determines the implications of states’ reopening (i.e., the...

Logo
354 Views
Share
•24 Jun 2019 08:30

Adaptive Biotechnologies IPO: Immune to Grow and Succeed; and the Future Looks Good

Adaptive Biotechnologies (ADPT US) has filed for an IPO in the US to raise approximately US$181m and has set an IPO price range of US$15-17 per...

Share
bullish•Personalis Inc
•18 Jun 2019 17:18

Personalis IPO: Personalising Cancer Trials and Treatments; Upside from Growth in Cancer Market

Personalis offers genomic sequencing to bio-pharmaceutical companies by fully analyzing sample tissue data of cancer patients. It provides its...

Share
No more insights
x